Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07446088Not ApplicableRecruiting

Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation

Role: lead

NCT07440927Not ApplicableRecruiting

Stress Urinary Incontinence for Female Patients (CGM MUIT-2301)

Role: lead

NCT05469295Not ApplicableCompleted

CETIC-I (CEra Traction Improves Cervical Kyphosis -I)

Role: lead

NCT05469282Not ApplicableCompleted

CEFID-I (CEra Flow Improves DVT-1)

Role: lead

NCT05549596Not ApplicableCompleted

CETIS-I (CEra Traction Improves Spine-I)

Role: lead

NCT05511064Not ApplicableCompleted

CEFID-II (CEra Flow Improves DVT-II)

Role: lead

All 6 trials loaded